Marcio Souza - 23 Mar 2023 Form 4 Insider Report for Praxis Precision Medicines, Inc. (PRAX)

Role: Chief Executive Officer, Director
Signature: /s/ Alex Nemiroff, as Attorney-in-Fact
Issuer symbol: PRAX
Transactions as of: 23 Mar 2023
Net transactions value: +$60,366
Form type: 4
Filing time: 27 Mar 2023, 13:12:20 UTC
Previous filing: 13 Jan 2023
Next filing: 18 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRAX	Common Stock	Purchase	$30,160	+35,000	+18%	$0.8617	226,299	23 Mar 2023	Direct	F1
transaction	PRAX	Common Stock	Purchase	$30,207	+35,002		$0.8630	35,002	23 Mar 2023	Held by spouse	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.86 to $0.863, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.
F2	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8572 to $0.8676, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.86 to $0.863, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8572 to $0.8676, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.